Results 231 to 240 of about 89,230 (317)

Contrast‐Enhanced Computed Tomography/Magnetic Resonance Imaging Is Useful for Surveying Gastroesophageal Varices in Patients After Fontan Surgery

Hepatology Research, EarlyView.
The presence of gastroesophageal varices (GEVs) following Fontan surgery (FS) could not be predicted by blood biochemical indices and other clinical factors, and contrast‐enhanced CT or MRI can be useful for surveying GEVs in patients following FS. ABSTRACT Objectives Liver cirrhosis (LC) is a common complication of Fontan surgery (FS) because of the ...
Takanori Suzuki, Kentaro Matsuura, Sayuri Yamabe, Kiyomi Kayama, Tsutomu Shinohara, Keiichi Itatani, Yoshiki Okamoto, Hayato Kawamura, Kei Fujiwara, Yoshihiro Seo, Hiromi Kataoka   +10 more
wiley   +1 more source

Clinical Analysis of Sinistral Portal Hypertension. [PDF]

Iran J Med Sci
Zheng J, Luo G, Deng MM.
europepmc   +1 more source

The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs

Hepatology Research, EarlyView.
The risk of HCC persists long after NUC initiation. In noncirrhotic patients, the risk remains stable more than 10 years after NUC treatment initiation. ABSTRACT Background and Aim Nucleos(t)ide analogs (NUCs) are used in the treatment of chronic hepatitis B (CHB).
Kazuhiro Murai, Hayato Hikita, Ryoko Yamada, Yuki Nishimura, Masanori Miyazaki, Hisashi Ishida, Atsushi Hosui, Ryotaro Sakamori, Nobuyuki Tatsumi, Kazuyoshi Ohkawa, Yoshinori Doi, Takatoshi Nawa, Satoshi Egawa, Yuichi Yoshida, Yasutoshi Nozaki, Kazuho Imanaka, Masanori Nakahara, Mitsuru Sakakibara, Takayuki Yakushijin, Hiroyuki Ogawa, Takeo Usui, Kengo Matsumoto, Tsugiko Oze, Shinji Kuriki, Emi Sometani, Jihyun Sung, Akiyoshi Shimoda, Satoshi Shigeno, Kazuki Maesaka, Kumiko Shirai, Akira Doi, Yuki Tahata, Yoshinobu Saito, Takahiro Kodama, Tomohide Tatsumi, Tomomi Yamada, Tetsuo Takehara   +36 more
wiley   +1 more source

Portal Systemic Shunt for Portal Hypertension

, 1972
Kuang-Yung Hsu
openalex   +2 more sources

EUS-guided portal pressure gradient measurement for evaluating the severity of portal hypertension: A retrospective analysis. [PDF]

Endosc Ultrasound
Luo R, Chen M, Lu H, Zhang R, Luo H, Liu Y, Liu X, Huang F, Deng G, Lei Z.   +9 more
europepmc   +1 more source

Lessons from implementation of a nephrology key performance indicator programme

Internal Medicine Journal, EarlyView.
Abstract Background We review the impact of a nephrology key performance indicator (KPI) program implemented over a ten‐year period in Victoria, Australia. The program enabled transparent comparison of performance across nephrology units, however improvement against performance targets was not consistent and better understanding of KPIs is required to ...
Adam G. Steinberg, Peter F. Mount, Maree Branagan, Matthew A. Roberts, Nigel D. Toussaint   +4 more
wiley   +1 more source

Hyperuricaemia in type 1 Gaucher disease: is uric acid a biomarker for disease severity?

Internal Medicine Journal, EarlyView.
Abstract Background Elevated serum uric acid (SUA) levels were observed in Gaucher disease type 1 (GD1) patients followed for two decades in northern Israel. There are no previous reports regarding hyperuricaemia in GD1 patients. Aims We aimed to evaluate the frequency of hyperuricaemia in GD1 patients and its correlation to disease severity ...
Zufit Hexner‐Erlichman, Salmas Watad, Jeff Szer, Nayaf Habashi, Hanna Rosenbaum   +4 more
wiley   +1 more source

Combined Caval and Portal Hypertension with Cirrhosis of the Liver

, 1973
Richard E. Welling, William V. McDermott
openalex   +2 more sources

Survival of patients with hepatopulmonary syndrome related to cirrhotic and non-cirrhotic (schistosomiasis) portal hypertension. [PDF]

World J Hepatol
Rolim MM, Farsoun LG, Luna CF, Markman-Filho B, Querette P, Lopes EP, Domingues AL.   +6 more
europepmc   +1 more source